<DOC>
	<DOCNO>NCT01356888</DOCNO>
	<brief_summary>The purpose study compare BIOTRONIK Orsiro Drug Eluting Stent System Abbott Xience Prime™ Drug Eluting Stent System respect in-stent Late Lumen Loss non-inferiority study de novo coronary lesion 9 month .</brief_summary>
	<brief_title>Study Orsiro Drug Eluting Stent System</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Main Subject provide write informed consent Single de novo lesion ≥ 50 % &lt; 100 % stenosis 2 coronary artery The target lesion length ≤ 26 mm The target reference vessel diameter ≥ 2.25 mm ≤ 4.0 mm Main Evidence myocardial infarction within 72 hour prior index procedure Unprotected leave main coronary artery disease ( stenosis &gt; 50 % ) Threevessel coronary artery disease time procedure Thrombus target vessel Target lesion involve side branch &gt; 2.0 mm diameter Heavily calcify lesion Target lesion locate supplied arterial venous bypass graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>